The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
Adriana Celesia(University of Palermo), Sonia Emanuele(University of Palermo)
Cited by 11
Related Papers
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
|Biomedicines|2022|46
Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)
|International Journal of Molecular Sciences|2023|13
The Antitumor Potential of Sicilian Grape Pomace Extract: A Balance between ROS-Mediated Autophagy and Apoptosis
|Biomolecules|2024|5
Targeting lipogenesis promotes the synergistic effect of the selective HDAC6 inhibitor ITF3756 with bortezomib in colon cancer cells
|Frontiers in Pharmacology|2025|0